The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32

Peptides

Volumn 18, Issue 10, 1997, Pages 1475-1481

  Hunt, P J ^a   Espiner, E A ^a   Nicholls, M G ^a   Richards, A M ^a   Yandle, T G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

BNP; Brain natriuretic peptide; Metabolism; ProBNP; Processing

Indexed keywords

AMINO ACID; ANTISERUM; BRAIN NATRIURETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD; CARBOXY TERMINAL SEQUENCE; CIRCULATION; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; METABOLISM; PLASMA; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOIMMUNOASSAY; SERUM;

EID: 0031409078     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00245-3     Document Type: Article

References (31)

1. Beaubien G., Schafer M. K., Weihe E., Dong W., Chretien M., Seidah N. G., Day R. The distinct gene expression of the prohormone convertases in the rat heart suggests potential substrates. Cell Tissue Res. 279:1995;539-549.
2. Bloch K. D., Scott J. A., Zisfein J. B., Fallon J. T., Margolies M. N., Seidman C. E., Matsueda G. R., Homcy C. J., Graham R. B., Seidman J. G. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science. 230:1985;1168-1171.
3. Bloch K. D., Seidman J. G., Naftilan J. D., Fallon J. T., Seidman C. E. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell. 47:1986;695-702.
4. Currie M. G., Geller D. M., Chao J., Margolius H. S., Needleman P. Kallikrein activation of a high molecular weight atrial peptide. Biochem. Biophys. Res. Commun. 120:1984;461-466.
5. Damodaran A., Harris R. B. N-Terminal sequence analysis of atrial granule serine proteinase purified by affinity chromatography. J. Protein Chem. 14:1995;441-449.
6. Davidson N. C., Coutie W. J., Struthers A. D. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. Circulation. 91:1995;1276.
7. Fischman A. J., Wildey G. M., Matsueda G. R., Margolies M. N., Zisfein J. B., Homcy C. J., Graham R. M. Specificity of serine proteases for cleavage sites on proAtrial Natriuretic Factor. Peptides. 9:1989;1275-1283.
8. Gibson T. R., Shields P. P., Glembotski C. C. The conversion of atrial natriuretic peptide (ANP)-(1-126) to ANP-(99-126) by rat serum contribution to ANP cleavage in isolated perfused rat hearts . Endocrinology. 120:1987;764-772.
9. Glembotski C. C., Gibson T. R. Molecular forms of immunoactive atrial natriuretic peptide released from cultured rat atrial myocytes. Biochem. Biophys. Res. Commun. 132:1985;1008-1017.
10. Hino J., Tateyama H., Minamino N., Kangawa K., Matsuo H. Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochem. Biophys. Res. Commun. 167:1990;693-700.
11. Holmes S. J., Espiner E. A., Richards A. M., Yandle T. G., Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 76:1993;91-96.
12. Hunt P. H., Yandle T. G., Nicholls M. G., Richards A. M., Espiner E. A. The amino-terminal portion of probrain natriuretic peptide (proBNP) circulates in human plasma. Biochem. Biophys. Res. Commun. 214:1995;1175-1183.
13. Hunt P. J., Richards A. M., Nicholls M. G., Yandle T. G., Doughty R. N., Espiner E. A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP) a new marker of cardiac impairment . Clin. Endocrinol. 47:1997;287-296.
14. Imada T., Takayanagi R., Inagami T. Atrioactivase, a specific peptidase in bovine atria for the processing of pro-atrial natriuretic factor. J. Biol. Chem. 263:1988;9515-9519.
15. Inagami T. Atrial natriuretic factor. J. Biol. Chem. 264:1989;3043-3046.
16. Kambayashi Y., Nakao K., Mukoyama M., Saito Y., Ogawa Y., Shiono S., Inouye K., Yoshida N., Imura H. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 259:1990;341-345.
17. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., Mukoyama M., Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 88:1993;82-91.
18. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., Shirakami G., Jougasaki M., Obata K., Yasue H., Kambayashi Y., Inouye K., Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans evidence for an exquisite dual natriuretic peptide system . J. Clin. Invest. 87:1991;1402-1412.
19. Murthy K. K., Thibault G., Cantin M. Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor). Biochem. J. 250:1988;665-670.
20. Sawada Y., Inoue M., Kanda T., Sakamaki T., Tanaka S., Minamino N., Nagai R., Takeuchi T. Co-elevation of brain natriuretic peptide and proprotein-processing endopeptidase furin after myocardial infarction in rats. FEBS Lett. 400:1997;177-182.
21. Sei C. A., Hand G. L., Murray S. F., Glembotski C. C. The cosecretional maturation of atrial natriuretic factor by primary atrial myocytes. Mol. Endocrinol. 6:1992;309-319.
22. Suzuki E., Hirata Y., Kohmoto O., Sugimoto T., Hayakawa H., Matsuoka H., Sugimoto T., Kojima M., Kangawa K., Minamino N., Matsuo H. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ. Res. 71:1992;1039-1048.
23. Tateyama H., Hino J., Minamino N., Kangawa K., Minamino T., Sakai K., Ogihara T., Matsuo H. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem. Biophys. Res. Commun. 185:1992;760-767.
24. Tateyama H., Hino J., Minamino N., Kangawa K., Ogihara T., Matsuo H. Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium. Biochem. Biophys. Res. Commun. 166:1990;1080-1087.
25. Thibault G., Murthy K., Gutkowska J., Seidah N. G., Lazure C., Chretien M., Cantin M. NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation identification, radioimmunoassay and half-life . Peptides. 9:1988;47-53.
26. Togashi K., Kameya T., Ando K., Marumo F., Kawakami M. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clinica Chimica Acta. 201:1991;193-200.
27. Wypij D. M., Harris R. B. Characterization of homogeneous atrial granule serine proteinase, a candidate processing enzyme of pro-atrial natriuretic factor. Life Sci. 50:1992;523-531.
28. Yandle T. G. Biochemistry of natriuretic peptides. J. Int. Med. 235:1994;561-576.
29. Yandle T., Richards A., Gilbert A., Fisher S., Holmes S., Espiner E. Assay of brain natriuretic peptide (BNP) in human plasma evidence for high molecular weight BNP as a major plasma component in heart failure . J. Clin. Endocrinol. Metab. 76:1993;832-838.
30. Yandle, T. G.; Veseley, D. V.; Hunt, P. J.; Espiner, E. A.; Richards, A. M.; Nicholls, M. G.; Sage, M. Intracardiac forms of BNP in humans: evidence for amino terminal BNP formation from proBNP prior to secretion. Tenth International Congress of Endocrinology P1:757; 1996(abstr).
31. Zisfein J. B., Graham R. M., Dreskin S. V., Wildey G. M., Fischman A. J., Homcy C. J. Characterization and purification of a protease in serum that cleaves proatrial natriuretic factor (proANF) to its circulating forms. Biochemistry. 26:1987;8690-8697.